Immunic (HAM:10V) Research & Development: €74.03 Mil (TTM As of Mar. 2026)


HAM:10V Immunic Inc HAM:10V
32 GF Score
Price €7.56
! 3 Warning Signs
View Full Analysis

What is Immunic Research & Development?

Immunic HAM:10V 32 Research & Development is €74.03 Mil as of Mar. 2026. GuruFocus rates HAM:10V with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Immunic's Research & Development for the three months ended in Mar. 2026 was €22.17 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €74.03 Mil.

Immunic  (HAM:10V) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Immunic Research & Development Related Terms

Immunic Research & Development Historical Data

* Premium members only.

The historical data trend for Immunic's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunic Research & Development Chart

Immunic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.09 67.27 76.31 76.44 70.01

Immunic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.92 18.53 17.05 16.29 22.17
HAM:10V
32GF Score
Immunic Inc HAM:10V
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunic Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €74.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €74.03 Mil mean?
Immunic (HAM:10V) has a Research & Development of €74.03 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Immunic and its competitors.
Is Immunic's Research & Development too high?
Immunic's current Research & Development is €74.03 Mil. Overall, Immunic has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Immunic's Research & Development compare to KPTI and INDP?
Immunic's Research & Development of €74.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Immunic and its competitors. Immunic's current Research & Development is €74.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunic stock overvalued right now?
Immunic (HAM:10V) has a current Research & Development of €74.03 Mil. The current Research & Development is €74.03 Mil. Immunic's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Immunic (HAM:10V), the current Research & Development is €74.03 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immunic Business Description

Other Exchanges IMUX:USA10V:Germany
Address 1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
32GF Score

Get the complete analysis for HAM:10V

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.56
Price